NCT05345639

Brief Summary

The main objective is to compare the effectiveness of LocoRegional Anesthesia (LRA) (bilateral transverse thoracic block or bilateral parasternal block) in addition to standard management compared to standard management alone (general anesthesia without LRA) on the FQoR-15 (French Quality of Recovery - 15 score) at H+24 after cardiac surgery by sternotomy.This is a phase III monocentric superiority study , comparative, with three parallel groups, randomized with a ratio (1:1:1), controlled versus standard management, single-blind.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
254

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Aug 2022

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 26, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2023

Completed
Last Updated

March 21, 2025

Status Verified

December 1, 2024

Enrollment Period

1 year

First QC Date

April 12, 2022

Last Update Submit

March 18, 2025

Conditions

Keywords

LRABlockERASFQOR-15QOR-15Transversus thoracic blockParasternal blockCardiac surgeryAnalgesiaPIP (parasternal intercostal plane block)Régional anesthesia

Outcome Measures

Primary Outcomes (1)

  • FQoR-15 score at 24 hours (French Quality of Recovery-15 score)

    Value of the French Quality of Recovery-15 score (minimum value of 0 and maximum value of 150, with a higher score for a better outcome). The QoR-15 questionnaires will be completed by the patient himself whenever possible, who could be helped by a nurse blinded to the assignment group.

    24 hours after surgery

Secondary Outcomes (12)

  • Pain (VRS) at rest and mobilisation

    3, 6, 12, 24, 48 , 72 hours after surgery and during the removal of surgical drains

  • Post-operative consumption of morphine (milligrams)

    3, 6, 12 hours after surgery and daily assessed at 24, 48, 72, 96 and 120 hours after surgery

  • Post-operative consumption of daily non-morphine analgesics (milligrams)

    24, 48, 72, 96 and 120 hours after surgery

  • Rate of painful patients

    24 and 48 hours after surgery

  • FQoR-15 score at 48 hours

    48 hours after surgery

  • +7 more secondary outcomes

Study Arms (3)

TTP group (= Transversus Thoracic Plane block = Deep PIP = Deep parasternal intercostal plane block)

EXPERIMENTAL

At the end of the surgery, realisation of a bilateral transverse thoracic block. (20ml of Naropeine 0.2%, each side) Followed by standard analgesic treatment.

Drug: LRA Loco-regional anesthesiaProcedure: Standardized post-operative analgesia protocol

PSB group (=ParaSternal Block = Superficial PIP = Superficial parasternal intercostal plane block)

EXPERIMENTAL

At the end of the surgery, realisation of a bilateral parasternal block (20ml of Naropeine 0.2%, each side). Followed by standard analgesic treatment.

Drug: LRA Loco-regional anesthesiaProcedure: Standardized post-operative analgesia protocol

Control group

SHAM COMPARATOR

Standard analgesic treatment alone (without LRA) .

Procedure: Standardized post-operative analgesia protocol

Interventions

Bilateral parasternal block or transverse thoracic block are performed ultrasound-guided, at the end of surgery in the operating room. Once in the desired plane depending on the randomisation (transverse or parasternal), a volume of 20 ml of ropivacaine at 2 mg/ml is injected on each side of the sternum. The intervention (TTP or PSB) is performed by the anesthetist-resuscitator investigator.

Also known as: 40ml Ropivacaine 0.2%
PSB group (=ParaSternal Block = Superficial PIP = Superficial parasternal intercostal plane block)TTP group (= Transversus Thoracic Plane block = Deep PIP = Deep parasternal intercostal plane block)

The pain management protocol in intensive care is as follows: * paracetamol 1g x 4 per day systematically (apart from the usual contraindications), IV then PO; * PCA (Patient Controlled Analgesia) with oxycodone or morphine: 1mg bolus, 7min refractory period, maximum 4h dose 20mg. The PCA is usually maintained until 24-48h after the intervention then relayed by oxycodone 5mg every 4h if EVA \> 3 sublingual and addition of oxycodone LP 10mg x 2 per day if daily intake on PCA \> 20mg. Remedy molecules in case of ineffective analgesia: ketoprofen 100mg q12h IV, or 50mg q8h PO; nefopam 20mg every 6h IV or PO; ketamine 1 to 1.5 mg/kg/24H IVSE.

Control groupPSB group (=ParaSternal Block = Superficial PIP = Superficial parasternal intercostal plane block)TTP group (= Transversus Thoracic Plane block = Deep PIP = Deep parasternal intercostal plane block)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient (≥18 years old);
  • Patient having scheduled cardiac surgery with a sternotomy performed at the CHU d'Angers;
  • Patient having signed a consent;
  • French-speaking patient, able to understand and answer a questionnaire;
  • Affiliated patient or beneficiary of a social security scheme.
  • Hemodynamic stability at the end of surgery;
  • Absence of bleeding justifying immediate revision surgery.
  • Known hypersensitivity to amide-bonded local anesthetics;
  • Operation for cardiac revision surgery, including sternotomy REDUX (revision surgery);
  • Emergency surgery;
  • Surgery in a septic context (Endocarditis, Intravascular device infection);
  • Weight less than 30kg;
  • Severe psychiatric or cognitive impairment interfering with assessment by questionnaires;
  • Pregnant, breastfeeding or parturient woman;
  • Person deprived of liberty by judicial or administrative decision;
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jeanneteau

Angers, maine et loire, 49933, France

Location

Related Publications (11)

  • Bignami E, Castella A, Pota V, Saglietti F, Scognamiglio A, Trumello C, Pace MC, Allegri M. Perioperative pain management in cardiac surgery: a systematic review. Minerva Anestesiol. 2018 Apr;84(4):488-503. doi: 10.23736/S0375-9393.17.12142-5. Epub 2017 Oct 12.

    PMID: 29027773BACKGROUND
  • Lahtinen P, Kokki H, Hynynen M. Pain after cardiac surgery: a prospective cohort study of 1-year incidence and intensity. Anesthesiology. 2006 Oct;105(4):794-800. doi: 10.1097/00000542-200610000-00026.

    PMID: 17006079BACKGROUND
  • Huang AP, Sakata RK. Pain after sternotomy - review. Braz J Anesthesiol. 2016 Jul-Aug;66(4):395-401. doi: 10.1016/j.bjane.2014.09.013. Epub 2016 Apr 23.

    PMID: 27343790BACKGROUND
  • McIsaac DI, Cole ET, McCartney CJ. Impact of including regional anaesthesia in enhanced recovery protocols: a scoping review. Br J Anaesth. 2015 Dec;115 Suppl 2:ii46-56. doi: 10.1093/bja/aev376.

    PMID: 26658201BACKGROUND
  • Ueshima H, Hara E, Marui T, Otake H. RETRACTED: The ultrasound-guided transversus thoracic muscle plane block is effective for the median sternotomy. J Clin Anesth. 2016 Mar;29:83. doi: 10.1016/j.jclinane.2015.10.014. Epub 2016 Feb 9. No abstract available.

    PMID: 26897453BACKGROUND
  • de la Torre PA, Garcia PD, Alvarez SL, Miguel FJ, Perez MF. A novel ultrasound-guided block: a promising alternative for breast analgesia. Aesthet Surg J. 2014 Jan 1;34(1):198-200. doi: 10.1177/1090820X13515902. No abstract available.

    PMID: 24396082BACKGROUND
  • Leger M, Campfort M, Cayla C, Parot-Schinkel E, Lasocki S, Rineau E. Validation of an alternative French version of the Quality of Recovery-15 Score: the FQoR-15. Br J Anaesth. 2020 Oct;125(4):e345-e347. doi: 10.1016/j.bja.2020.05.052. Epub 2020 Jul 9. No abstract available.

    PMID: 32654751BACKGROUND
  • Kleif J, Waage J, Christensen KB, Gogenur I. Systematic review of the QoR-15 score, a patient- reported outcome measure measuring quality of recovery after surgery and anaesthesia. Br J Anaesth. 2018 Jan;120(1):28-36. doi: 10.1016/j.bja.2017.11.013. Epub 2017 Nov 22.

    PMID: 29397134BACKGROUND
  • Myles PS, Boney O, Botti M, Cyna AM, Gan TJ, Jensen MP, Kehlet H, Kurz A, De Oliveira GS Jr, Peyton P, Sessler DI, Tramer MR, Wu CL; StEP-COMPAC Group; Myles P, Grocott M, Biccard B, Blazeby J, Boney O, Chan M, Diouf E, Fleisher L, Kalkman C, Kurz A, Moonesinghe R, Wijeysundera D. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: patient comfort. Br J Anaesth. 2018 Apr;120(4):705-711. doi: 10.1016/j.bja.2017.12.037. Epub 2018 Feb 2.

    PMID: 29576111BACKGROUND
  • Demarquette A, Jeanneteau A, Blanchard-Daguet A, Fouquet O, Parot-Schinkel E, Lasocki S, Rineau E, Leger M. Impact of superficial and deep parasternal blocks on recovery after cardiac surgery with sternotomy: a randomised controlled trial. Br J Anaesth. 2025 Sep;135(3):764-771. doi: 10.1016/j.bja.2025.05.043. Epub 2025 Jul 9.

  • Jeanneteau A, Demarquette A, Blanchard-Daguet A, Fouquet O, Lasocki S, Riou J, Rineau E, Leger M. Effect of superficial and deep parasternal blocks on recovery after cardiac surgery: study protocol for a randomized controlled trial. Trials. 2023 Jul 6;24(1):444. doi: 10.1186/s13063-023-07446-2.

MeSH Terms

Conditions

Pain, PostoperativeBites and StingsAgnosia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPoisoningChemically-Induced DisordersWounds and InjuriesPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Randomization takes place during surgery. Bilateral parasternal block or transverse thoracic block are performed ultrasound-guided, under general anesthesia.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Study phase III, superiority study, monocentric, comparative, with three parallel groups, randomized with a ratio (1:1:1), controlled versus standard care, single-blind
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2022

First Posted

April 26, 2022

Study Start

August 1, 2022

Primary Completion

August 8, 2023

Study Completion

September 7, 2023

Last Updated

March 21, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

The data will be collected in a coded manner: 1st letter of the surname, 1st letter of the patient's first name, serial number of inclusion in the center by the physicians investigating the study in the electronic observation notebook of the study ( EnnovClinical) managed by the DRCI of the CHU of Angers.

Locations